Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700016060

Trial Profile

Clinical Trials Insight: 700016060

Phase of Trial: Phase I

Latest Information Update: 29 Jul 2008

At a glance

  • Drugs Adomiparin (Primary)
  • Indications Acute coronary syndromes; Thromboembolism
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Momenta Pharmaceuticals
  • Most Recent Events

    • 29 Jul 2008 Results presented at the World Conference on Clinical Pharmacology and Therapeutics.
    • 04 Apr 2008 Results will be presented at the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
    • 04 Apr 2008 Status changed from in progress to completed according to a Momenta Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top